NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

代謝體學市場:全球產業趨勢,佔有率,規模,成長,機會,預測(2021∼2026年)

Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版商 IMARC Services Private Limited 商品編碼 1015556
出版日期 內容資訊 英文 143 Pages
商品交期: 2-3個工作天內
價格
代謝體學市場:全球產業趨勢,佔有率,規模,成長,機會,預測(2021∼2026年) Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
出版日期: 2021年06月15日內容資訊: 英文 143 Pages
簡介

全球代謝體學的市場規模,從2015年到2020年顯示了強力的成長。該市場預計從2021年到2026年之間以約10%的年複合成長率擴大。

癌症與其他慢性疾病的盛行率上升,是促進市場成長的重要要素之一。再加上個人化醫療的需求高漲,以及製藥產業大幅增加也推動市場成長。此外,代謝體學和機器學習(ML)的整合,也推動市場成長。預計在都市化迅速和生物科技領域的廣泛研究開發(R&D)活動等,今後數年也帶動市場。

本報告提供代謝體學市場相關調查,市場概要,以及各產品,各適應症,各用途,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 範圍與調查手法

第3章 摘要整理

第4章 簡介

第5章 全球代謝體學市場

  • 市場概要
  • 市場效能
  • COVID-19的影響

第6章 市場區隔,各產品

  • 代謝體學設備
  • 代謝體學生物資訊學工具與服務

第7章 市場區隔,各適應症

  • 癌症
  • 心血管障礙
  • 神經學的障礙
  • 先天性代謝異常症
  • 其他

第8章 市場區隔,各用途

  • 生物標記與藥物研發
  • 毒物學
  • 營養基因學
  • 個人化醫療
  • 其他

第9章 市場區隔,各地區

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 各國市場區隔

第10章 SWOT分析

第11章 價值鏈分析

第12章 波特五力分析

第13章 競爭情形

  • 市場結構
  • 主要參與者
  • 主要參與者的簡介
    • Agilent Technologies Inc.
    • Biocrates Life Sciences AG
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Danaher Corporation
    • Human Metabolome Technologies Inc.
    • Metabolon Inc.
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
目錄
Product Code: SR1020D276_Report

The global metabolomics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026. Metabolomics refers to the large-scale study of metabolites, or small molecules, in cells, biofluids, tissues and organisms. It is an analytical approach for systematic metabolic profiling and fingerprinting in various biological samples and systems. It consists of various detection techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), along with separation techniques, such as gas chromatography. These techniques are commonly used for metabolome studies, toxicology testing and developing personalized medicine. They also provide an assessment of health and an insight into the causes and treatment of medical ailments, such as cardiovascular and neurological diseases and cancer.

The increasing prevalence of cancer and other chronic diseases is one of the key factors driving the growth of the market. Furthermore, a significant increase in the pharmaceutical industry, along with the rising demand for personalized medicines, is also providing a boost to the market growth. Metabolomics facilitates the study of genes and proteins, along with the development of biomarkers that aid in the discovery and development of medicines and managing disease progression. Additionally, the integration of metabolomics with machine learning (ML) is also favoring the market growth. ML aids in the accurate interpretation of data generated using the NMR and MS techniques and automates complex, repetitive and time-consuming processes. Advanced ML software also offers comprehensive analysis and visualization functions for the representation of large amounts of data. Other factors, including rapid urbanization and extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market in the upcoming years.

Breakup by Product:

  • Metabolomics Instruments
  • Metabolomics Bioinformatics Tools and Services

Breakup by Indication:

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others

Breakup by Application:

  • Biomarker and Drug Discovery
  • Toxicology
  • Nutrigenomics
  • Personalized Medicine
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Human Metabolome Technologies Inc., Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Questions Answered in This Report:

  • How has the global metabolomics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global metabolomics market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global metabolomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Metabolomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Metabolomics Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Metabolomics Bioinformatics Tools and Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiovascular Disorders
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurological Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Inborn Errors of Metabolism
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Biomarker and Drug Discovery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Toxicology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nutrigenomics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Personalized Medicine
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Biocrates Life Sciences AG
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Bio-Rad Laboratories Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bruker Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Danaher Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Human Metabolome Technologies Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Metabolon Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Shimadzu Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Thermo Fisher Scientific Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Waters Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Metabolomics Market: Major Drivers and Challenges
  • Figure 2: Global: Metabolomics Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Metabolomics Market: Breakup by Product (in %), 2020
  • Figure 4: Global: Metabolomics Market: Breakup by Indication (in %), 2020
  • Figure 5: Global: Metabolomics Market: Breakup by Application (in %), 2020
  • Figure 6: Global: Metabolomics Market: Breakup by Region (in %), 2020
  • Figure 7: Global: Metabolomics Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 8: Global: Metabolomics (Metabolomics Instruments) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 9: Global: Metabolomics (Metabolomics Instruments) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 10: Global: Metabolomics (Metabolomics Bioinformatics Tools and Services) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: Metabolomics (Metabolomics Bioinformatics Tools and Services) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: Metabolomics (Cancer) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Metabolomics (Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Metabolomics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Metabolomics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Metabolomics (Neurological Disorders) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Metabolomics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Metabolomics (Inborn Errors of Metabolism) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Metabolomics (Inborn Errors of Metabolism) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Metabolomics (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Metabolomics (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Metabolomics (Biomarker and Drug Discovery) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Metabolomics (Biomarker and Drug Discovery) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Metabolomics (Toxicology) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Metabolomics (Toxicology) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Metabolomics (Nutrigenomics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Metabolomics (Nutrigenomics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Metabolomics (Personalized Medicine) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Metabolomics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Metabolomics (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Metabolomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: North America: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: North America: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: United States: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: United States: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: Canada: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: Canada: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Asia Pacific: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Asia Pacific: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: China: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: China: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Japan: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Japan: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: India: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: India: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: South Korea: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: South Korea: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Australia: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: Australia: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Indonesia: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Indonesia: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 52: Others: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 53: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 54: Europe: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 55: Europe: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 56: Germany: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 57: Germany: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 58: France: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 59: France: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 60: United Kingdom: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 61: United Kingdom: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 62: Italy: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 63: Italy: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Spain: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Spain: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Russia: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Russia: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: Others: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 70: Latin America: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 71: Latin America: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 72: Brazil: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 73: Brazil: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 74: Mexico: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 75: Mexico: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 76: Others: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 77: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 78: Middle East and Africa: Metabolomics Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 79: Middle East and Africa: Metabolomics Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 80: Global: Metabolomics Industry: SWOT Analysis
  • Figure 81: Global: Metabolomics Industry: Value Chain Analysis
  • Figure 82: Global: Metabolomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Metabolomics Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Metabolomics Market Forecast: Breakup by Product (in Million US$), 2021-2026
  • Table 3: Global: Metabolomics Market Forecast: Breakup by Indication (in Million US$), 2021-2026
  • Table 4: Global: Metabolomics Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 5: Global: Metabolomics Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 6: Global: Metabolomics Market: Competitive Structure
  • Table 7: Global: Metabolomics Market: Key Players